DMG & Partners has raised Raffles Medical Group’s (RAFG.SI) target price to $2.09 from $1.86 and maintained its “buy” rating.
Raffles Medical, being the second-largest private healthcare provider in Singapore, has benefitted from renewed interest in the stable and defensive healthcare sector after Khazanah and Fortis Healthcare (FOHE.BO) started a bidding war for Parkway Holdings (PARM.SI), DMG said in a report.



